GVR Report cover Myopia And Presbyopia Treatment Market Size, Share & Trends Report

Myopia And Presbyopia Treatment Market Size, Share & Trends Analysis Report By Myopia Treatment Type (Corrective, Surgical, Drugs), By Presbyopia Treatment Type, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-3-68038-678-3
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Report Overview

The global myopia and presbyopia treatment market size was valued at USD 16.47 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2022 to 2030. Increasing cases of vision loss mainly due to myopia and rising incidence of distance vision impairment due to uncorrected myopia are some of the major factors expected to augment the overall market growth. In addition, the growing prevalence of presbyopia on a global scale is expected to foster the growth of the market over the forecast period. More than 2.1 billion individuals around the world suffered from presbyopia in 2020. Out of these individuals, one-third are aged more than 50 years. Nearly 128 million people in the U.S. are living with presbyopia. According to the WHO, in 2020, nearly 826 million were affected by unaddressed presbyopia. In addition, the number of presbyopia is the largest in East Asia, South Asia, and Southeast Asia, reporting more than twice that of other regions. Hence, the developing countries are expected to witness significant growth during the forecast period.

Canada myopia treatment market size, by type, 2020 - 2030 (USD Million)

The growing geriatric population that is prone to vision loss and aging adults (individuals above 40 years of age) across the globe are fueling the market growth. Most adults in their mid-40s start developing age and lifestyle-associated vision myopia treatment types. These myopia treatment types are expected to grow into myopia and presbyopia, thus augmenting the demand for myopia and presbyopia treatment. Undiagnosed presbyopia is one of the major challenges, which is expected to have a high impact on the vision care industry. The pathophysiology of presbyopia is still unclear to many people, thereby resulting in late diagnosis and increased treatment costs.

People already affected with myopia or presbyopia have started opting for telemedicine in the midst of COVID-19. With the widespread adoption of telemedicine, eye care professionals and regular consultants are continuing the monitoring of myopia progression, creating minimal impact on market growth. Many medical practices and hospitals are affected during the COVID-19 pandemic owing to several changes in protocols. The ophthalmology procedures are also affected in this novel disease outbreak as health checkups including ophthalmology were reduced due to COVID-19 restrictions. Due to the increased risk of spreading infection through contact lenses, many people opt for LASIK surgery for vision correction. Such reductions in elective ophthalmic surgeries are anticipated to create a negative impact on the overall market growth.

Additionally, the introduction of advanced lenses such as intraocular phakic presbyopic lenses and implantable contact lenses is expected to drive the market during the forecast period. These lenses are expected to gain enough popularity owing to their benefits. They have the capability of correcting a significant degree of nearsightedness, are less prone to dry eyes, can be surgically removed, and can be ideally used for non-LASIK patients.

PresbyLASIK is one of the advanced options available for the correction of presbyopia. This involves the usage of laser therapy for inducing spherical aberration to make the cornea multifocal. Another advanced option for presbyopic patients includes corneal inlays. Currently, only two corneal inlays are approved for the correction of presbyopia. The increasing number of ongoing studies and a wide product pipeline are the factors expected to boost the market growth.

Myopia Treatment Type Insights

The single prescription lenses segment held the largest revenue share of over 30.0% in 2021. This is due to the increasing prevalence of myopia in developing countries. The growing patient pool is contributing to the growing demand for corrective lenses. Features of the surgery such as minimally invasiveness, accuracy, and speed are also affecting the popularity of the surgery, thereby driving the adoption of myopia and presbyopia treatment.

Technologically advanced solutions are helping to significantly decrease the average turnaround time for ophthalmic surgeries. The increasing availability of advanced equipment and decreasing service costs are expected to boost the demand for surgeries during the forecast period.

Presbyopia Treatment Type Insights

Prescription lenses captured the largest revenue share of more than 25.0% in 2021. Contact lenses are also categorized as bifocal, multifocal, monovision, and modified monovision. Conductive keratoplasty, LASIK, LASEK, and PRK are effective refractive surgical procedures used for the treatment of presbyopia. LASIK is a widely accepted surgical procedure for the treatment of presbyopia. The surgery involves the reshaping of the cornea to improve far vision. Hence, the high prevalence of these myopia treatment types and growing demand for LASIK surgery are expected to foster the market growth during the forecast period.

Global myopia and presbyopia treatment market share, by type, 2021 (%)

The progressive multifocals segment is expected to be the fastest-growing segment over the forecast period owing to the increasing preference for correcting presbyopia. They are widely accepted due to aesthetic and visual advantages, such as image clarity while rejecting image jumping during eye movements. In addition, innovations in multifocals, such as multifocals incorporated with anti-reflexive coating and photochromic lenses, are expected to propel the growth of the segment during the forecast period.

Regional Insights

North America dominated the market with over 20.0% share in 2021 and is expected to maintain its lead over the forecast period owing to the availability of advanced technologies for treating the targeted myopia treatment types and the presence of a large number of market players. Asia Pacific is expected to be the fastest-growing region over the forecast period owing to the geriatric population growth, the high prevalence of eye-related myopia treatment types, and growing medical tourism.

In addition, the rising disposable income of consumers is expected to drive the market for myopia and presbyopia treatment in the APAC region. Europe is expected to witness growth in the coming years owing to the growing geriatric population and increasing awareness regarding the treatment of targeted myopia treatment type.

Key Companies & Market Share Insights

Market players are focusing on adopting growth strategies, such as innovations in the existing technologies, the launch of efficient techniques, and mergers and acquisition. Significant investment in R&D is undertaken by market leaders to enable early diagnosis and identify efficient and quick operative techniques. This ensures novelty in the field and concretes market position. Increased collaborations are undertaken by major players like Johnson and Johnson, Essilor, and Zeimer Ophthalmic Systems AG to develop advanced techniques and treatment strategies to provide improved and efficient treatment for myopia and presbyopia.

In July 2021, Essilor launched a progressive web app version of the pre-existing Essilor Companion for all eye care professionals. This initiative aims to streamline the digital ecosystem for Essilor’s industry partners, including Eye Care Professionals (ECPs), and offers a superior in-store digital Essilor brand experience. Such initiatives are likely to enhance their market presence.

Some of the prominent players in global myopia and presbyopia treatment market include:

  • Ziemer Ophthalmic Systems AG


  • Johnson & Johnson Vision

  • Essilor Ltd.

  • Zeiss International


  • Bausch & Lomb Incorporated

  • Haag-Streit UK

  • Topcon Corporation

Myopia And Presbyopia Treatment Market Report Scope

Report Attribute


The market size value in 2022

USD 17.4 billion

Revenue forecast in 2030

USD 33.7 billion

Growth Rate

CAGR of 8.5% from 2022 to 2030

Base year for estimation


Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; India; China; Thailand; South Korea; Brazil; Mexico; Argentina; Columbia; South Africa; Saudi Arabia; UAE

Key companies profiled

Ziemer Ophthalmic Systems AG; NIDEK CO., LTD.; Johnson & Johnson Vision; Essilor Ltd.; Zeiss International; ALCON VISION LLC; Bausch & Lomb Incorporated; Haag-Streit UK; Topcon Corporation

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global myopia and presbyopia treatment market report based on type and region:

  • Myopia Treatment Type Outlook (Revenue, USD Million, 2017 - 2030)

    • Corrective

      • Prescription Lenses

        • Single

        • Bifocal

        • Trifocal

        • Others

      • Contact Lenses

    • Surgical

    • Drugs

  • Presbyopia Treatment Type Outlook (Revenue, USD Million, 2017 - 2030)

    • Prescription Lenses

      • Reading Glasses

      • Bifocals

      • Trifocals

      • Progressive Multifocals

      • Office Progressives

    • Contact Lenses

      • Bifocal

      • Multifocal

      • Monovision

      • Modified Monovision

    • Intraocular Lenses

    • Refractive Surgery

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)
    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Columbia

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon